http://www.channelnewsasia.com/stories/health/view/1167146/1/.html
lingering questions persist about their long-term safety ....
Researchers at the Heart Protection Study Collaborative Group in Oxford ....
those who took the statins saw a reduction in "bad" LDL cholesterol and a 23-per cent reduction in episodes of vascular ill-health compared to the placebo group.
lingering questions persist about their long-term safety ....
Researchers at the Heart Protection Study Collaborative Group in Oxford ....
those who took the statins saw a reduction in "bad" LDL cholesterol and a 23-per cent reduction in episodes of vascular ill-health compared to the placebo group.